Beam Therapeutics Cash Flow Statement
NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Beam Therapeutics free cash flow
In fiscal 2025, Beam Therapeutics generated -$345.1 million of operating cash flow and spent $14.9 million on capital expenditures. That left free cash flow of -$360.0 million, a free-cash-flow margin of -257.7% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Beam Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -79.99M | -376.74M | -132.53M | -289.09M | -370.64M | -194.59M | -78.33M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | 22.29M | 21.93M | 20.01M | 14.15M | 7.45M | 4.74M | 3.50M |
| Stock-Based Compensation | 94.24M | 120.66M | 98.65M | 84.32M | 43.57M | 15.38M | 7.03M |
| Change in Working Capital | -124.87M | -40.06M | -173.76M | -41.30M | 349.72M | -5.67M | 2.83M |
| Operating Cash Flow | -345.10M | -347.25M | -149.19M | 22.53M | -66.27M | -95.74M | -72.00M |
| Capital Expenditures | -14.95M | -8.95M | -33.73M | -48.95M | -46.81M | -16.36M | -12.52M |
| Investing Cash Flow | -121.44M | 185.01M | 71.84M | -461.34M | -294.14M | -100.12M | -66.66M |
| Financing Cash Flow | 478.05M | 7.74M | 276.45M | 111.59M | 756.14M | 322.32M | 41.28M |
| Net Change in Cash | 11.51M | -154.50M | 199.09M | -327.22M | 395.73M | 126.46M | -97.38M |
| Free Cash Flow | -360.05M | -356.19M | -182.93M | -26.42M | -113.08M | -112.10M | -84.52M |
This table shows 7 annual periods of Beam Therapeutics's cash flow statement, from FY 2025 back to FY 2019, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BEAM's reporting calendar. What is a cash flow statement?